New Threads Only:  Add to Google Reader or Homepage
New Threads & Replies:  Add to Google Reader or Homepage
Forums are for serious investors only. GuruFocus Forum Rules.

Forum List » Business News and Headlines
SEC Filings, Earing Reports, Press Releases
New Topic Search
Goto Thread: PreviousNext
Goto: Forum ListMessage ListNew TopicSearchLog In
Misonix Announces New HIFU Distribution Agreement for Italy
Posted by: gurufocus (IP Logged)
Date: January 5, 2009 04:02PM

Press Release: Misonix Announces New HIFU Distribution Agreement for Italy Misonix Inc. designs develops manufactures and markets medical scientific and industrial ultrasonic equipment laboratory safety equipment and air pollution control products. Misonix's ultrasonic platform is the basis for several innovative medical technologies. Misonix has a minority equity position in Focus Surgery Inc. which uses high intensity focused ultrasound technology to destroy deep-seated cancerous tissues without affecting surrounding healthy tissue. Misonix acquired worldwide rights to use the Focus technology in kidney liver and breast treatment. Addressing a combined market estimated to be in excess of $four billion annually Misonix's proprietary ultrasonic medical devices are used for wound debridement cosmetic surgery neurosurgery laparoscopic surgery and other surgical and medical applications. MISONIX Inc. has a market cap of $4.7 million; its shares were traded at around $0.86 with and P/S ratio of 0.1.

More on MSON: Gurus buys and sells of MSON 10-year financial history of MSON. Insider buys/sells of MSON.

Press Release:

FARMINGDALE, N.Y., Jan. 5 /PRNewswire-FirstCall/ -- Misonix, Inc. (Nasdaq: MSON), a developer of minimally invasive ultrasonic medical device technology, which in Europe is used for the ablation of tumors and worldwide for other acute health conditions, has entered into a definitive, 3-year distribution agreement with Alliance Lithomobile, a Division of Alliance Medical S.r.L., based in Milano, Italy. This agreement supersedes the interim agreement announced on November 7, 2008. Under the terms of the agreement, Lithomobile will emphasize the Sonablate(R) 500 High Intensity Focused Ultrasound ("HIFU") System as a mobile, "fee for use" service to hospitals throughout Italy. Secondarily, Alliance Lithomobile will be responsible for capital sales of the Sonablate when appropriate. Misonix and Alliance Lithomobile will share the "fee for use" revenue for the length of the agreement plus an additional 3 years. Purchase minimums for both "fee per use" and capital sales are part of the agreement.

Alliance Lithomobile is well known in Italy as a premier distributor of mobile lithotripsy services, as well as their successful representation of capital equipment for oncology and other medical specialties.

The Sonablate is a state of the art HIFU instrument used for the trans-rectal ablation of tumors of the prostate gland. Characteristics of HIFU, when used for this purpose, are clinical outcomes similar to other treatment modalities, but with low instances of urinary incontinence and sexual impotence.

"Misonix is pleased to partner with Lithomobile to provide prostate HIFU treatment for prostate cancer to hospitals throughout Italy. Lithomobile's reputation as a high-profile distributor of advanced medical equipment in Italy is well known to us," said Michael A. McManus, Jr., President and Chief Executive Officer of Misonix. "Lithomobile's experience with the mobile fee for service business segment makes Lithomobile a particularly appealing distribution partner, whose strengths blend well with Misonix's business strategy for HIFU."

About Misonix:

Misonix, Inc. (NASDAQ: MSON) designs, develops, manufactures and markets therapeutic ultrasonic medical devices and laboratory equipment. Misonix's therapeutic ultrasonic platform is the basis for several innovative medical technologies. Addressing a combined market estimated to be in excess of $3 billion annually; Misonix's proprietary ultrasonic medical devices are used for wound debridement, cosmetic surgery, neurosurgery, laparoscopic surgery, and other surgical and medical applications. Additional information is available on the Company's Web site at www.misonix.com.

With the exception of historical information contained in this press release, content herein may contain "forward looking statements" that are made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. These statements are based on management's current expectations and are subject to uncertainty and changes in circumstances. Investors are cautioned that forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from the statements made. These factors include general economic conditions, delays and risks associated with the performance of contracts, risks associated with international sales and currency fluctuations, uncertainties as a result of research and development, acceptable results from clinical studies, including publication of results and patient/procedure data with varying levels of statistical relevancy, risks involved in introducing and marketing new products, potential acquisitions, consumer and industry acceptance, litigation and/or court proceedings, including the timing and monetary requirements of such activities, the timing of finding strategic partners and implementing such relationships, regulatory risks including approval of pending and/or contemplated 510(k) filings, the ability to achieve and maintain profitability in the Company's business lines, and other factors discussed in the Company's Annual Report on Form 10-K, subsequent Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. The Company disclaims any obligation to update its forward-looking relationships.

Investor Relations Contact:
    Cameron Associates, Inc.
    212-245-4577
    Kevin@cameronassoc.com

Source: PRNewsWire

More on MSON: Gurus buys and sells of MSON 10-year financial history of MSON. Insider buys/sells of MSON.



Stocks Discussed: MSON,
Rate this post:




Sorry, only registered users may post in this forum.

Please Login if you have an account or Create a Free Account if you don't




Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial